PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm

Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have poor outcomes despite intensive chemotherapy, underscoring the need for novel therapeutic approaches. The expression status of PD1/PD-L1 in BPDCN remains unknown. We evaluated PD1/PD-L1 by immunohistochemistry and RNAseq express...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Phyu P. Aung, Narittee Sukswai, Reza Nejati, Sanam Loghavi, Weina Chen, Carlos A. Torres-Cabala, C. Cameron Yin, Marina Konopleva, Xiaofeng Zheng, Jing Wang, Zhenya Tang, L. Jeffrey Medeiros, Victor G. Prieto, Naveen Pemmaraju, Joseph D. Khoury
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2019-05-01
Colecção:Cancers
Assuntos:
PD-L1
immunotherapy
RNA sequencing
immune checkpoint regulation
Acesso em linha:https://www.mdpi.com/2072-6694/11/5/695
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados